ART4 and COVID-19: Furthermore, a comprehensive study exploring multiple antibody targets ranked anti-cardiolipin and anti-platelet glycoprotein autoantibodies as the leading factors that could be associated with COVID-19 severity, which lends credibility to their possible contribution to hypercoagulability63.